Salmonella Typhi carriage and gallbladder cancer
People who carry typhoid bacteria in their gallbladder for years have roughly four to five times the risk of gallbladder cancer. Laboratory work shows the bacterium can push already-damaged gallbladder cells towards cancer.
Overview
Chronic carriage of Salmonella enterica serovar Typhi in the gallbladder, often on stones, is the infectious risk factor for gallbladder cancer in the Indian subcontinent and historically in Chile. A Chilean case-control study (39 cases, 40 gallstone controls, 39 population controls) found higher Vi antibody titres in cases (odds ratio 4.0, 95% CI 0.9 to 18.3) although the organism was not recovered from bile, stones, tissue or stool; the accompanying meta-analysis of more than 1,000 cases gave a summary relative risk of 4.6 (95% CI 3.1 to 6.8) for anti-Vi antibody and 5.0 (2.7 to 9.3) for bile or stool culture (Koshiol 2016). Mechanistically, Salmonella enterica induced malignant transformation in predisposed mice, murine gallbladder organoids and fibroblasts carrying TP53 mutation and c-MYC amplification; effector proteins secreted during infection activated MAPK and AKT signalling, which was needed both to start and to sustain transformation, consistent with observations in Indian patients (Scanu 2015). The finding gives a biological reason for the very early age of onset in India and for typhoid control and cholecystectomy of carriers as prevention.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · TP53 is the 'guardian of the genome', broken in half of all cancers. Fixing it directly has so far defeated every attempt, so drugs exploit what its loss makes cancers depend on.
Showing the target this term concerns: TP53.
The quantitative case for typhoid as a gallbladder carcinogen, complementing the mechanism from Scanu 2015. Vaccination, sanitation and treating chronic carriers are the population-level levers this implies.
A mechanism for the oldest epidemiological clue in gallbladder cancer, and a reason the disease appears so early in India. It frames typhoid control and cholecystectomy in chronic carriers as cancer prevention, and MAPK and AKT as pathways worth watching in infection-associated tumours.
Similar pages
not linked directly; found by shared links- TermPhosphorylation
- Key paperIntegrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes
Shares TP53, Gallbladder cancer.
- Key paperGeographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis
Shares TP53, Gallbladder cancer.
- TermDownstream and upstream
- Key paperWhole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
Shares TP53, Gallbladder cancer.
- Key paperThe mutational landscape and actionable targets of gallbladder cancer: an ancestry-informed and comparative analysis of a Chilean population
Shares TP53, Gallbladder cancer.
- PathwayMicroRNAs in cancer
Shares PI3K / AKT / mTOR, TP53, RAS / RAF / MEK / ERK (MAPK).
- IdeaMilestone prizes for first-in-class mechanisms reaching human proof of concept
Shares TP53, RAS / RAF / MEK / ERK (MAPK).